Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Aldevron logo — A world where every cure is possible.

Aldevron

A world where every cure is possible.

Founded 1998 United States Fargo, United States 744 employees Acquired Total: $9.60B Biotechnology, Industrial +1

General Information

Company Name Aldevron
Founded Year 1998
Location United States Fargo, United States
Founders / Decision Makers
Team member Team member
Employees 744
Industries Biotechnology, Industrial, Manufacturing
Funding Stage Acquired
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Aldevron. To contact Aldevron, visit aldevron.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aldevron compare?

A PDF of Aldevron and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aldevron soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aldevron

Aldevron, founded in 1998, operates in the fields of Biotechnology, Industrial, and Manufacturing, with its headquarters located in the United States. The company aims to foster a world where "every cure is possible." This mission aligns with its focus on leveraging advanced scientific and technological solutions to enhance global healthcare improvements.

As a part of Danaher, Aldevron benefits from the corporation's broad expertise and expansive resources. The collaboration with Danaher's other businesses in Biotechnology, Diagnostics, and Life Sciences places Aldevron in a strategic position to exploit cutting-edge technologies for transformative health impacts worldwide.

In a significant move, Danaher invested $9.60B to acquire Aldevron on 01 June 2021. This acquisition underscores Danaher's commitment to enhancing its industry leadership and signals potential growth and innovation opportunities for Aldevron through enhanced synergies and resource optimization.

Business keywords: Contract Manufacturing, Plasmid DNA Production, Protein Production, Antibody Discovery, mRNA Production, Recombinant Proteins, CRISPR/Cas9, cGMP, GMP-Source, Gene Therapy, Cell Therapy, Vaccine Development, Gene Editing, Life Sciences Solutions

Services & Products

Custom Manufacturing Solutions
Regulatory Support
Gene Editing Products
RNA Design and Manufacturing
Analytics Services
Drug Substance Manufacturing
Fill/Finish Capabilities

Target Customers

Biotechnology Companies Pharmaceutical Companies Research Institutions Clinical Researchers Gene Therapy Developers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $9.60B 1
Danaher
01 Jun 2021
Buyout Undisclosed 1
EQT Group
01 Jul 2019
Growth Equity VC Undisclosed 1
TA Associates
TA Associates
01 Jan 2017

Aldevron Alternatives & Competitors

View All Alternatives
Aldevron vs
AGC Biologics
AGC Biologics United States

We work side by side with our customers to improve patients’ lives by bringing new biopharmaceutical...

Venture round
2531 employees
Biotechnology, Industrial
Aldevron vs
FUJIFILM Biotechnologies
FUJIFILM Biotechnologies United States

Partners for Life, Advancing Tomorrow's Medicines

5920 employees
Biotechnology, Health Care
Aldevron vs
Ascend Advanced Therapies
Ascend Advanced Therapies United States

Ascend is an advanced therapy development partner with a flexible platform featuring industry-leadin...

Series A
101 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Aldevron

A world where every cure is possible.
Aldevron was founded in 1998.
Aldevron is headquartered in Fargo, United States.
Aldevron operates in Biotechnology, Industrial and Manufacturing. Its work centres on Contract Manufacturing, Plasmid DNA Production, Protein Production and Antibody Discovery. Its customers include Biotechnology Companies, Pharmaceutical Companies and Research Institutions.
Aldevron has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Aldevron has approximately 744 employees.
Aldevron has completed 3 funding rounds, raising a total of $9.60B. The latest funding stage is Acquired.
Aldevron offers: Custom Manufacturing Solutions, Regulatory Support, Gene Editing Products, RNA Design and Manufacturing, Analytics Services, Drug Substance Manufacturing, Fill/Finish Capabilities.
Top alternatives and competitors to Aldevron include AGC Biologics, FUJIFILM Biotechnologies, Ascend Advanced Therapies, RoslinCT, 53Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aldevron and AGC Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aldevron, https://bouncewatch.com/company/aldevron, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes